Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.

Autor: Erika Mileti, Gianluca Matteoli, Iliyan D Iliev, Maria Rescigno

Publikováno v: PLoS ONE, Vol 4, Iss 9, p e7056 (2009)

BACKGROUND: While the use of probiotics to treat or prevent inflammatory bowel disease (IBD) has been proposed, to this point the clinical benefits have been limited. In this report we analyzed the immunological activity of three strains of Lactobaci

Externí odkaz: https://doaj.org/article/474322189f4e4bcfb524da442fcf0bc7

Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy

Autor: Erika Mileti, Clorinda Ciafardini, S. Costa, M.C. Fantini, Stefano Mazza, Flavio Caprioli, Marina Mapelli, Markus F. Neurath, Marta Rachele Stefanucci, Sergio Pinto, Federica Facciotti, Daniele Noviello, Sebastiano Pasqualato, Agnese Favale, Maurizio Vecchi, Roberto Bertè, Raja Atreya

Publikováno v: Journal of Crohn's & Colitis
Journal of Crohns and Colitis

Background and AimsA similar course of COVID-19 in patients with inflammatory bowel diseases [IBD] and in the general population has been reported. However, disease prevalence in IBD patients is presently unknown. In this prospective observational st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127adbb66b5e1cac754f9bf17ecf6dbe
http://europepmc.org/articles/PMC7717179

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development

Autor: Erika Mileti, Luciano Adorini, Marcel Sorribas, Reiner Wiest, Ilaria Spadoni, Maria Rescigno, Pietro Invernizzi, Marianna Galbiati, Giuseppe Penna, Paola Brescia, Alessandra Silvestri, Juliette Mouriès

Publikováno v: Journal of Hepatology
Mouries, Juliette; Brescia, Paola; Silvestri, Alessandra; Spadoni, Ilaria; Sorribas, Marcel; Wiest, Reiner; Mileti, Erika; Galbiati, Marianna; Invernizzi, Pietro; Adorini, Luciano; Penna, Giuseppe; Rescigno, Maria (2019). Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. Journal of hepatology, 71(6), pp. 1216-1228. Elsevier 10.1016/j.jhep.2019.08.005

Graphical abstract
Highlights • During diet-induced dysbiosis the gut vascular barrier is disrupted. • Gut vascular barrier disruption is responsible for the translocation of bacteria or bacterial products systemically. • Inhibiting gut va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6a1b2f8ae683055c75ffc66eeab2fc
https://pubmed.ncbi.nlm.nih.gov/31419514

Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction

Autor: Erika Mileti, Elisa Mazzini, Maria Rescigno, Marcello Chieppa, Gianluca Matteoli, Francesca Fallarino, Iliyan D. Iliev, Paolo Puccetti

Publikováno v: Gut

Objective CD103 + gut dendritic cells (DCs) have been shown to be required for de novo conversion of adaptive T regulatory (Treg) cells. Indoleamine 2,3-dioxygenase (IDO) is an enzyme involved in tryptophan catabolism that is expressed by DCs isolate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b16bf65f41221191d3a989f1048f24e
http://hdl.handle.net/11391/808698

Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy

Autor: Maria Rescigno, Erika Mileti, Iliyan D. Iliev, Gianluca Matteoli

Publikováno v: PLoS ONE, Vol 4, Iss 9, p e7056 (2009)
PLoS ONE

BACKGROUND: While the use of probiotics to treat or prevent inflammatory bowel disease (IBD) has been proposed, to this point the clinical benefits have been limited. In this report we analyzed the immunological activity of three strains of Lactobaci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::201e5185fb1b69f95ca5e33f787b39a1
http://europepmc.org/articles/PMC2738944?pdf=render